These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8001234)

  • 1. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
    Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ
    Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
    Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
    Lubet RA; Szabo E; Christov K; Bode AM; Ericson ME; Steele VE; Juliana MM; Grubbs CJ
    Mol Cancer Ther; 2008 Apr; 7(4):972-9. PubMed ID: 18375820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea.
    Knott KK; McGinley JN; Lubet RA; Steele VE; Thompson HJ
    Breast Cancer Res Treat; 2001 Dec; 70(3):171-83. PubMed ID: 11804181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
    Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
    Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.
    Rodríguez-Burford C; Lubet RA; Steele VE; Eto I; Bandy M; Juliana MM; Weiss HL; Grizzle WE; Kelloff GJ; Grubbs CJ
    Oncol Rep; 2001; 8(2):373-9. PubMed ID: 11182059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced Cancers.
    Lubet RA; Heckman-Stoddard BM; Fox JT; Moeinpour F; Juliana MM; Shoemaker RH; Grubbs CJ
    Cancer Prev Res (Phila); 2020 Mar; 13(3):283-290. PubMed ID: 31871222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prepubertal zearalenone exposure suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis but causes severe endocrine disruption in female Sprague-Dawley rats.
    Nikaido Y; Yoshizawa K; Pei RJ; Yuri T; Danbara N; Hatano T; Tsubura A
    Nutr Cancer; 2003; 47(2):164-70. PubMed ID: 15087269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.
    Moon RC; Steele VE; Kelloff GJ; Thomas CF; Detrisac CJ; Mehta RG; Lubet RA
    Anticancer Res; 1994; 14(3A):889-93. PubMed ID: 8074489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
    Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
    Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
    Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
    Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
    Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
    Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.
    Coombes RC; Wilkinson JR; Bliss JM; Shah P; Easton DF; Dowsett M
    Br J Cancer; 1991 Aug; 64(2):247-50. PubMed ID: 1892751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of letrozole in the model of premenopausal mammary carcinogenesis.
    Kubatka P; Sadlonova V; Kajo K; Nosalova G; Fetisovova Z
    Neoplasma; 2008; 55(1):42-6. PubMed ID: 18190239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY; Garrett WM; Brodie AM
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat.
    Desaulniers D; Leingartner K; Russo J; Perkins G; Chittim BG; Archer MC; Wade M; Yang J
    Environ Health Perspect; 2001 Jul; 109(7):739-47. PubMed ID: 11485874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
    De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
    Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models.
    Lubet RA; Steele VE; Juliana MM; Bode A; Moeinpour F; Grubbs CJ
    Oncol Rep; 2018 Sep; 40(3):1545-1553. PubMed ID: 29565450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
    Lee S; Simpson M; Nimmo M; Xu Z
    Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.